Loading...
Coherus BioSciences will see 16% revenue growth driving future value
n/a
n/a
neofeudal's Fair Value
n/a
1Y
44.6%7D
-10.3%1Y
44.6%7D
-10.3%You can edit this narrative until May 14 2:40 AM. Then, changes will post as Updates.
You can edit this narrative until May 14 2:40 AM. Then, changes will post as Updates.